{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:28:06Z","timestamp":1777922886313,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:p>\n                    Eleven clinical\n                    <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                    fluoroquinolone-resistant isolates were tested to access the potential of adjuvant therapies to reduce antimicrobial resistance using fixed concentrations of the chemosensitizers chlorpromazine (CPZ), thioridazine (TZ), phenylalanine-arginine-\u03b2-naphthylamide (PA\u03b2N), and 1-(1-naphthylmethyl)-piperazine-(NMP) with varying concentrations of antimicrobial agents nalidixic acid (NAL), ciprofloxacin (CIP), moxifloxacin (MXF), tetracycline (TET), and chloramphenicol (CHL). Ethidium bromide dye was used together with the chemosensitizers to investigate permeabilization effects. NMP was assessed for its capacity to reduce the mass of biofilm alone and in combination with CIP and MXF. Of the selected chemosensitizers, NMP exhibited the greatest capacity to reverse resistance and inhibit efflux, based on the concentrations tested. Susceptibility to antimicrobial agents including (fluoro)quinolones, TET, and CHL were found to be increased in the presence of NMP, in a concentration-dependent manner. PA\u03b2N also demonstrated similar effects when combined with the chemosensitizers tested. In the case of half of the isolates studied, NMP alone reduced preformed biofilm biomass. Combinations of latter along with CIP or MXF were also found to reduce the mass of preformed biofilm, in the case of only some of the bacterial isolates. The capacity of NMP to reduce antimicrobial resistance could be of relevance as a strategy to limit bacterial colonization on abiotic surfaces.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2017.0386","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T11:57:52Z","timestamp":1531483072000},"page":"1497-1506","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Reversing Antimicrobial Resistance in Multidrug-Resistant\n                    <i>Klebsiella pneumoniae<\/i>\n                    of Clinical Origin Using 1-(1-Naphthylmethyl)-Piperazine"],"prefix":"10.1177","volume":"24","author":[{"given":"Jo\u00e3o","family":"Anes","sequence":"first","affiliation":[{"name":"University College Dublin","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Martins","sequence":"additional","affiliation":[{"name":"University College Dublin","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9amus","family":"Fanning","sequence":"additional","affiliation":[{"name":"University College Dublin","place":["Ireland"]},{"name":"Queen's University Belfast","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,12,8]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"O'Neill J. 2014. The review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. Available at: https:\/\/amr-review.org\/Publications.html (accessed July3 2018)."},{"key":"e_1_3_3_3_2","unstructured":"World Health Organization. 2014. Antimicrobial Resistance: Global Report on Surveillance. World Health Organization Geneva."},{"key":"e_1_3_3_4_2","first-page":"1","volume":"13","author":"Meek R.W.","year":"2015","unstructured":"Meek R.W., , Vyas H., and L.J.V. Piddock. 2015. Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol., 13:1\u201311.","journal-title":"Nonmedical uses of antibiotics: time to restrict their use? PLoS Biol."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2014.00145"},{"key":"e_1_3_3_6_2","unstructured":"Centres for Disease Control and Prevention. 2013. Antimicrobial Resistance Threaths in the United States. Centres for Disease Control and Prevention Atlanta GA."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13040426"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028X-68.10.2022"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-11-32"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.589"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01020-07"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2016.02.018"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.103896"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens3030743"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399410001766"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4781"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-827X(01)01002-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01866-13"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03283-14"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801307010083"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.849-852.2005"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki446"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki445"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2014.05.013"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060666"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00421"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01913"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/1754-1611-3-18"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.73"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01053-10"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"e0135198","DOI":"10.1371\/journal.pone.0135198","article-title":"Polymyxin E induces rapid Paenibacillus polymyxa death by damaging cell membrane while Ca2+ can protect cells from damage","volume":"10","author":"Yu Z.","year":"2015","unstructured":"Yu Z., , Cai Y., , Qin W., , Lin J., , and Qiu J.. 2015. Polymyxin E induces rapid Paenibacillus polymyxa death by damaging cell membrane while Ca2+ can protect cells from damage. PLoS One, 10:e0135198.","journal-title":"PLoS One"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.212"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.09.003"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501049112"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku340"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.04.007"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.08.003"},{"key":"e_1_3_3_38_2","first-page":"Doc15","article-title":"Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients","volume":"8","author":"Pakzad I.","year":"2013","unstructured":"Pakzad I., , Zayyen Karin M., , Taherikalani M., , Boustanshenas M., , and Lari A.R.. 2013. Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients. GMS Hyg. Infect. Control, 8:Doc15.","journal-title":"GMS Hyg. Infect. Control"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.02.008"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00725-13"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq1296"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00205-X"},{"key":"e_1_3_3_43_2","first-page":"751","article-title":"Non-antibiotics reverse resistance of bacteria to antibiotics","volume":"24","author":"Kristiansen J.E.","year":"2010","unstructured":"Kristiansen J.E., , Thomsen V.F., , Martins A., , Viveiros M., , and Amaral L.. 2010. Non-antibiotics reverse resistance of bacteria to antibiotics. In Vivo, 24:751\u2013754.","journal-title":"In Vivo"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.040204-0"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00661-08"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.09.027"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl081"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn466"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119064"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.65.2.232-260.2001"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3155"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-180-2_15"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00803"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu286"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt069"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03775-14"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2017.08.024"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.105-116.2001"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01310-08"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2517"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(00)01913-2"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03865.x"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.04.054"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2017.0386","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2017.0386","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2017.0386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:32:49Z","timestamp":1777667569000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mdr.2017.0386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12,1]]}},"alternative-id":["10.1089\/mdr.2017.0386"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2017.0386","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}